AACE发布有关睾酮治疗心血管风险的立场声明

2015-10-08 国际循环编辑部 国际循环

近期,美国临床内分泌医师协会(AACE)发布了立场声明,认为目前缺乏睾酮替代治疗可导致心血管事件的证据。 AACE生殖内分泌科学委员会兼迈阿密大学米勒医学院的Neil Goodman呼吁开展更多规模的研究探讨睾酮替代治疗对心血管疾病风险的影响。虽然近期发表的一些研究支持睾酮浓度较低可导致心血管问题,尤其是在老年男性中,但是AACE的立场声明强调“睾酮浓度低通常是心血管疾病的标志物,而并非病因

近期,美国临床内分泌医师协会(AACE)发布了立场声明,认为目前缺乏睾酮替代治疗可导致心血管事件的证据。

AACE生殖内分泌科学委员会兼迈阿密大学米勒医学院的Neil Goodman呼吁开展更多规模的研究探讨睾酮替代治疗对心血管疾病风险的影响。虽然近期发表的一些研究支持睾酮浓度较低可导致心血管问题,尤其是在老年男性中,但是AACE的立场声明强调“睾酮浓度低通常是心血管疾病的标志物,而并非病因”。实际上,睾酮治疗能为性腺功能减退症男性带来改善胰岛素抵抗、减小腰围、降低脂肪含量等方面的获益,还能逆转代谢综合征。

AACE生殖内分泌科学委员会认为,对拟行睾酮替代治疗的男性应进行彻底的诊断工作,根据患者的症状、体征及睾酮浓度而非潜在病因来指导治疗决策。另外,委员会强调,睾酮替代治疗的风险/获益比仍未完全明确。鉴于睾酮浓度较低通常是慢性疾病的标志物,有必要对接受睾酮治疗进行潜在心血管危险因素干预;合并血管症状的轻度性腺功能减退症患者行睾酮治疗时应更慎重,在行睾酮治疗前医生应与患者进行充分的沟通与讨论。

原文标题:

AACE releases position statement on testosterone therapy, CV events

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2082365, encodeId=738c2082365d3, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Thu Feb 25 11:16:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699186, encodeId=c38e16991869c, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Thu Oct 22 10:16:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655725, encodeId=47321655e25c5, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Wed Jan 06 22:16:00 CST 2016, time=2016-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384610, encodeId=d538138461024, content=<a href='/topic/show?id=3beae3105da' target=_blank style='color:#2F92EE;'>#睾酮治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73105, encryptionId=3beae3105da, topicName=睾酮治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e875489, createdName=wenjie, createdTime=Sat Oct 10 00:16:00 CST 2015, time=2015-10-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2082365, encodeId=738c2082365d3, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Thu Feb 25 11:16:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699186, encodeId=c38e16991869c, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Thu Oct 22 10:16:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655725, encodeId=47321655e25c5, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Wed Jan 06 22:16:00 CST 2016, time=2016-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384610, encodeId=d538138461024, content=<a href='/topic/show?id=3beae3105da' target=_blank style='color:#2F92EE;'>#睾酮治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73105, encryptionId=3beae3105da, topicName=睾酮治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e875489, createdName=wenjie, createdTime=Sat Oct 10 00:16:00 CST 2015, time=2015-10-10, status=1, ipAttribution=)]
    2015-10-22 zgwhgch
  3. [GetPortalCommentsPageByObjectIdResponse(id=2082365, encodeId=738c2082365d3, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Thu Feb 25 11:16:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699186, encodeId=c38e16991869c, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Thu Oct 22 10:16:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655725, encodeId=47321655e25c5, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Wed Jan 06 22:16:00 CST 2016, time=2016-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384610, encodeId=d538138461024, content=<a href='/topic/show?id=3beae3105da' target=_blank style='color:#2F92EE;'>#睾酮治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73105, encryptionId=3beae3105da, topicName=睾酮治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e875489, createdName=wenjie, createdTime=Sat Oct 10 00:16:00 CST 2015, time=2015-10-10, status=1, ipAttribution=)]
    2016-01-06 shanyongle
  4. [GetPortalCommentsPageByObjectIdResponse(id=2082365, encodeId=738c2082365d3, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Thu Feb 25 11:16:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699186, encodeId=c38e16991869c, content=<a href='/topic/show?id=1349166054' target=_blank style='color:#2F92EE;'>#AACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1660, encryptionId=1349166054, topicName=AACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca229920897, createdName=zgwhgch, createdTime=Thu Oct 22 10:16:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655725, encodeId=47321655e25c5, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Wed Jan 06 22:16:00 CST 2016, time=2016-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384610, encodeId=d538138461024, content=<a href='/topic/show?id=3beae3105da' target=_blank style='color:#2F92EE;'>#睾酮治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73105, encryptionId=3beae3105da, topicName=睾酮治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e875489, createdName=wenjie, createdTime=Sat Oct 10 00:16:00 CST 2015, time=2015-10-10, status=1, ipAttribution=)]